Molecular mechanisms involved in the protective actions of Selective Estrogen Receptor Modulators in brain cells
dc.creator | Baez-Jurado E. | |
dc.creator | Rincón-Benavides M.A. | |
dc.creator | Hidalgo-Lanussa O. | |
dc.creator | Guio-Vega G. | |
dc.creator | Ashraf G.M. | |
dc.creator | Sahebkar A. | |
dc.creator | Echeverria V. | |
dc.creator | Garcia-Segura L.M. | |
dc.creator | Barreto G.E. | |
dc.date.accessioned | 2020-09-02T22:12:36Z | |
dc.date.accessioned | 2022-11-08T20:19:00Z | |
dc.date.available | 2020-09-02T22:12:36Z | |
dc.date.available | 2022-11-08T20:19:00Z | |
dc.date.created | 2020-09-02T22:12:36Z | |
dc.date.issued | 2019 | |
dc.identifier | 52, , 44-64 | |
dc.identifier | 00913022 | |
dc.identifier | https://hdl.handle.net/20.500.12728/3669 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5142970 | |
dc.language | en | |
dc.publisher | Academic Press Inc. | |
dc.subject | Astrocytes | |
dc.subject | Brain pathologies | |
dc.subject | Estrogen receptors | |
dc.subject | GRP30 | |
dc.subject | SERMs | |
dc.subject | Tamoxifen | |
dc.subject | afimoxifene | |
dc.subject | cre recombinase | |
dc.subject | droloxifene | |
dc.subject | drug metabolite | |
dc.subject | endoxifen | |
dc.subject | estrogen receptor | |
dc.subject | G protein coupled receptor 30 | |
dc.subject | hydroxytamoxifen | |
dc.subject | inositol 1,4,5 trisphosphate receptor | |
dc.subject | inositol 1,4,5 trisphosphate receptor 2 | |
dc.subject | Notch1 receptor | |
dc.subject | raloxifene | |
dc.subject | selective estrogen receptor modulator | |
dc.subject | tamoxifen | |
dc.subject | unclassified drug | |
dc.subject | estrogen receptor | |
dc.subject | neuroprotective agent | |
dc.subject | selective estrogen receptor modulator | |
dc.subject | astrocyte | |
dc.subject | brain cell | |
dc.subject | brain damage | |
dc.subject | cell differentiation | |
dc.subject | cell fate | |
dc.subject | cell function | |
dc.subject | cell interaction | |
dc.subject | central nervous system disease | |
dc.subject | drug mechanism | |
dc.subject | drug response | |
dc.subject | human | |
dc.subject | LoxP site | |
dc.subject | memory | |
dc.subject | microglia | |
dc.subject | nerve cell | |
dc.subject | nervous system inflammation | |
dc.subject | neural stem cell | |
dc.subject | neuroprotection | |
dc.subject | nonhuman | |
dc.subject | priority journal | |
dc.subject | Review | |
dc.subject | animal | |
dc.subject | brain disease | |
dc.subject | drug effect | |
dc.subject | metabolism | |
dc.subject | Animals | |
dc.subject | Astrocytes | |
dc.subject | Brain Diseases | |
dc.subject | Humans | |
dc.subject | Neuroprotective Agents | |
dc.subject | Raloxifene Hydrochloride | |
dc.subject | Receptors, Estrogen | |
dc.subject | Selective Estrogen Receptor Modulators | |
dc.subject | Tamoxifen | |
dc.title | Molecular mechanisms involved in the protective actions of Selective Estrogen Receptor Modulators in brain cells | |
dc.type | Review |